RxDoctor Payments DataLook up a doctor →

Christopher Huser, MD

Pain Medicine · Englewood, CONPI 1932206604

Payments from drug & device makers

$14,017in general payments, 2019–2025

Across 614 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • AbbVie$2K
  • Collegium Pharmaceutical, Inc.$941
  • Amgen$522
  • Scilex Pharmaceuticals Inc.$479
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$443
  • plus $7K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific46$2,663
AbbVie(2 entities)121$2,053
Collegium Pharmaceutical, Inc.60$941
Amgen(2 entities)21$522
Scilex Pharmaceuticals Inc.30$479
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$443
Abbott10$435
Lilly USA, LLC25$399
Lundbeck LLC18$365
Zyla Life Sciences, Inc.59$349
MML US, Inc.4$349
Medtronic6$326
Stimwave Technologies Incorporated5$304
Pfizer17$298
Vertos Medical, Inc.2$297
Averitas Pharma Inc.13$288
Saluda Medical Americas, Inc.6$285
GRT US Holding, Inc.12$214
Nalu Medical, Inc.2$205
Nevro Corp.8$205
Painteq LLC2$187
Biodelivery Sciences International, Inc.10$169
Stryker1$163
Novartis10$157
Relievant Medsystems, Inc.2$157
Sentynl Therapeutics, Inc.13$145
SPR Therapeutics, Inc4$121
IBSA Pharma Inc.6$115
Teva Pharmaceuticals USA, Inc.7$113
Biohaven Pharmaceutical Holding Company Ltd.5$98
Biohaven Pharmaceuticals, Inc.5$96
Almatica Pharma LLC4$95
Pacira Therapeutics, Inc.5$85
Bioventus LLC4$76
Takeda Pharmaceuticals U.S.A., Inc.5$74
Radius Health, Inc.4$74
Daiichi Sankyo Inc.4$69
Kaleo, Inc.3$60
Zimmer Biomet3$54
MDD US Operations, LLC4$50
Vertex3$48
Spinal Simplicity, LLC2$47
Merck2$35
Tonix Medicines, Inc.1$31
Convatec Inc.1$30
Redhill Biopharma Inc.2$28
Upsher-smith Laboratories LLC2$25
Si-bone, Inc.1$23
Idorsia Pharmaceuticals US Inc1$22
Shionogi Inc1$19
Assertio Therapeutics, Inc.1$18
Azurity Pharmaceuticals, Inc.1$18
Promius Pharma LLC1$17
Curonix LLC1$15
Eisai Inc.1$13
Kowa Pharmaceuticals America, Inc.1$13
Impel Pharmaceuticals Inc.1$13
Supernus Pharmaceuticals, Inc.1$13
Johnson & Johnson1$12

How this compares

$14,017 in reported general payments places this provider in the 80th percentile of 96 pain medicine providers in Colorado.

See all pain medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$297,768
Medicare patients
661
Services billed
2,767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →